BusinessCompany NewsBillion dollar restatement for US drugs giant

Billion dollar restatement for US drugs giant

Pharmaceuticals giant Bristol-Myers Squibb is to restate its accounts, lowering sales revenues by $2bn (£1.3bn).

Link: Merck misses £8bn in accounts

The restatement will affect the accounts for 2002 and 2001 and will delay publication of the company’s third quarter results. The company also said sales for 2002 should be revised upwards.

The difficulties appear to stem from challenges to the company’s revenue recognition policy.

A statement from the company said: ‘The restatement is expected to reflect primarily adjustments in the timing of revenue recognition of the company’s USpharmaceutical sales to certain of its wholesalers.’

Related Articles

BDO replaces Deloitte as Mitie auditor

Audit BDO replaces Deloitte as Mitie auditor

3m Emma Smith, Managing Editor
CVR Global appoints partner in London office

Company News CVR Global appoints partner in London office

7m Alia Shoaib, Reporter
FTSE100 failing to provide adequate ethics information

Company News FTSE100 failing to provide adequate ethics information

7m Alia Shoaib, Reporter
Moore Stephens recruits new private client partner

Accounting Firms Moore Stephens recruits new private client partner

10m Emma Smith, Managing Editor
Magma Group announces merger, partner promotions

Accounting Firms Magma Group announces merger, partner promotions

10m Emma Smith, Managing Editor
BDO on ‘recruitment spree’ with multiple partner appointments

Accounting Firms BDO on ‘recruitment spree’ with multiple partner appointments

10m Emma Smith, Managing Editor
Brand strength leads to fee income growth for RSM

Accounting Firms Brand strength leads to fee income growth for RSM

10m Emma Smith, Managing Editor
Mazars strengthens audit team with partner appointment

Accounting Firms Mazars strengthens audit team with partner appointment

10m Emma Smith, Managing Editor